Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
Steffin DHM, Muhsen IN, Hill LC, Ramos CA, Ahmed N, Hegde M, Wang T, Wu M, Gottschalk S, Whittle SB, Lulla PD, Mamonkin M, Omer B, Rouce RH, Heczey A, Metelitsa LS, Grilley BJ, Robertson C, Torrano V, Lapteva N, Gee AP, Rooney CM, Brenner MK, Heslop HE. Steffin DHM, et al. Among authors: whittle sb. Blood. 2022 Jul 7;140(1):16-24. doi: 10.1182/blood.2022015728. Blood. 2022. PMID: 35325065 Free PMC article.
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors.
Whittle SB, Smith V, Silverstein A, Parmeter M, Minard CG, Bernhardt MB, Zage PE, Venkatramani R, Nuchtern JG, Heczey A, Russell HV, Shohet JM, Foster JH. Whittle SB, et al. Pediatr Blood Cancer. 2020 Oct;67(10):e28417. doi: 10.1002/pbc.28417. Epub 2020 Jul 30. Pediatr Blood Cancer. 2020. PMID: 32729196 Free PMC article. Clinical Trial.
Pediatric liposarcoma: A case series and literature review.
Baday YI, Navai SA, Hicks MJ, Venkatramani R, Whittle SB. Baday YI, et al. Among authors: whittle sb. Pediatr Blood Cancer. 2021 Dec;68(12):e29327. doi: 10.1002/pbc.29327. Epub 2021 Sep 14. Pediatr Blood Cancer. 2021. PMID: 34520106 Review.
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.
Miller A, Daum R, Wang T, Wu M, Tat C, Pfeiffer T, Navai S, Heczey A, Hegde M, Ahmed N, Whittle SB, Hill L, Martinez C, Krance R, Ramos CA, Rouce RH, Lulla P, Heslop HE, Omer B, Shekar M. Miller A, et al. Among authors: whittle sb. Cytotherapy. 2024 Sep;26(9):1026-1032. doi: 10.1016/j.jcyt.2024.04.075. Epub 2024 May 8. Cytotherapy. 2024. PMID: 38819365
Regression of a congenital mesoblastic nephroma.
Whittle S, Gosain A, Brown PY, Debelenko L, Raimondi S, Wilimas JA, Jenkins JJ, Davidoff AM. Whittle S, et al. Pediatr Blood Cancer. 2010 Aug;55(2):364-8. doi: 10.1002/pbc.22486. Pediatr Blood Cancer. 2010. PMID: 20582939 Free PMC article.
Congenital spindle cell rhabdomyosarcoma.
Whittle SB, Hicks MJ, Roy A, Vasudevan SA, Reddy K, Venkatramani R. Whittle SB, et al. Pediatr Blood Cancer. 2019 Nov;66(11):e27935. doi: 10.1002/pbc.27935. Epub 2019 Jul 24. Pediatr Blood Cancer. 2019. PMID: 31339226 Review.
Blood product administration during high risk neuroblastoma therapy.
Silverstein A, Reddy K, Smith V, Foster JH, Russell HV, Whittle SB. Silverstein A, et al. Among authors: whittle sb. Pediatr Hematol Oncol. 2020 Feb;37(1):5-14. doi: 10.1080/08880018.2019.1668095. Epub 2019 Dec 12. Pediatr Hematol Oncol. 2020. PMID: 31829069 Free PMC article.
27 results